Curis
CRIS
#11081
Rank
NZ$1.14 M
Marketcap
NZ$0.59
Share price
-17.89%
Change (1 day)
-78.59%
Change (1 year)

Curis (CRIS) - Net assets

Net assets on the balance sheet as of March 2026 : NZ$21.62 Million

According to Curis's latest financial reports the company has NZ$21.62 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Curis - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$NZ$9.43 M-188.68%
2024-12-31$-NZ$10.64 Million-134.19%
2023-12-31$NZ$31.1 M-57.58%
2022-12-31$NZ$73.32 M-44.79%
2021-12-31$NZ$0.13 B-26.67%
2020-12-31$NZ$0.18 B-459.67%
2019-12-31$-NZ$50.36 Million651.22%
2018-12-31$-NZ$6.71 Million-119.84%
2017-12-31$NZ$33.78 M-20.04%
2016-12-31$NZ$42.24 M-55.18%
2015-12-31$NZ$94.25 M147.96%
2014-12-31$NZ$38.01 M-30.85%
2013-12-31$NZ$54.97 M31.97%
2012-12-31$NZ$41.65 M-18.47%
2011-12-31$NZ$51.09 M-13.4%
2010-12-31$NZ$58.99 M29.65%
2009-12-31$NZ$45.5 M-29.06%
2008-12-31$NZ$64.14 M4.89%
2007-12-31$NZ$61.15 M20.02%
2006-12-31$NZ$50.95 M-8.35%
2005-12-31$NZ$55.59 M-17.89%
2004-12-31$NZ$67.7 M13.24%
2003-12-31$NZ$59.78 M68.75%
2002-12-31$NZ$35.43 M-85.44%
2001-12-31$NZ$0.24 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
NZ$153.82 B 711,350.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$34.20 B 158,096.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ$45.6 M 110.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$3.29 B 15,133.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$0.77 B 3,490.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ$11.69 M-45.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.89 B 4,016.63%๐Ÿ‡บ๐Ÿ‡ธ USA